GPs in England are now allowed to prescribe Mounjaro to severely obese people who also suffer from a range of other health ...

The mass rollout of weight loss jabs such as Mounjaro on the NHS in England will begin today as GPs are allowed to prescribe the drugs for the ...

Mounjaro offers up to 20% weight loss – but it’s not for everyone. Learn about eligibility, alternatives and why long-term ...

Shares in two companies slide as Danish drugmaker accuses US telehealth group of deceptively marketing replica treatments ...

Shares in Novo Nordisk fell as much as 3.5 per cent on Monday after detailed trial data on its experimental obesity drug ...

Novo Nordisk said it will stop selling Wegovy on Hims & Hers, claiming the telehealth company sold knockoff versions of the ...

Hims & Hers stock plunged around 30% on Monday after drugmaker Novo Nordisk abruptly ended a month-long collaboration to make ...

The Wegovy maker says the telehealth company didn't stop selling compounded versions of the blockbuster drug after Novo ...

In a first round human trial slimmers in Sweden taking the new drug-currently known as ATR-258-found they burnt fat yet ...

Obesity remains one of the most pressing, and preventable, health challenges of our time. The UK is one of a number of countries undoubtedly ...

When it comes to obesity, the United States often tops the charts. But did you know there are nations where obesity rates ...

While Eli Lilly brushed off concerns about gastrointestinal side effects for oral weight loss candidate orforglipron, ...